Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8049 POSTS
0 Comments
https://blstimes.com
People on the Move
Calviri Appoints Marc Wolff Chief Executive Officer
Life Sciences Times
-
April 12, 2021
0
Pharma
Exscientia Announces First AI-Designed Immuno-Oncology Drug to Enter Clinical Trials
Life Sciences Times
-
April 9, 2021
0
Public Health
LUCIRA COVID-19 Test Kit Identifies Viral Variants
Life Sciences Times
-
April 9, 2021
0
Pharma
Dicerna Sells OXLUM Royalty Interest to Royalty Pharma
Life Sciences Times
-
April 8, 2021
0
Life Sciences
TriSalus Life Sciences and MD Anderson Announce Strategic Research Collaboration
Life Sciences Times
-
April 8, 2021
0
Medtech
908 Devices Provides Handheld Mass Spec to U.S. Border Patrol
Life Sciences Times
-
April 8, 2021
0
Venture Capital
Oxford Finance Closes Credit Facility with Renalogic
Life Sciences Times
-
April 8, 2021
0
Life Sciences
Covid antibodies spike in breast milk after vaccination: Study
Life Sciences Times
-
April 7, 2021
0
Public Health
‘All US adults will be eligible for vax by April 19’
Life Sciences Times
-
April 7, 2021
0
Public Health
AstraZeneca’s UK vaccine trial on kids comes to a halt
Life Sciences Times
-
April 7, 2021
0
1
...
771
772
773
...
805
Page 772 of 805
TOP AUTHORS
Life Sciences Times
8049 POSTS
0 Comments
https://blstimes.com
Most Read
WHOOP Plans to Add More Than 600 Employees in 2026 as Global Expansion Accelerates
March 4, 2026
Physicians Increasingly Concerned About Affordable Healthcare Access, athenahealth Survey Finds
March 4, 2026
CordenPharma Colorado Expands Peptide Development Operations with New Lease at Boulder’s Flatiron Park
March 4, 2026
Affinia Therapeutics Receives FDA Fast Track Designation for AFTX-201 Gene Therapy for BAG3-Associated Dilated Cardiomyopathy
March 4, 2026